THC Therapeutics (THCT) Debt by Year
THC Therapeutics Inc carried $707K in long-term debt against $35 in cash and equivalents at the end of fiscal year 2024. Long-term debt was unchanged from the prior fiscal year. The table below carries 13 fiscal years, from 2008 to 2024, and the quarters THC Therapeutics Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
THCT Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K | FY0810-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $707K0.0% | $707K+22.7% | $576K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $35+250.0% | $10-68.8% | $32-100.0% | $296K+584.9% | $43K-86.4% | $318K+10595.6% | $3K | $15K-73.1% | $56Kn/m | $0-100.0% | $11K | N/A | N/A |
THCT Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $707K0.0% | $576K | $576K | $576K | $707K+22.7% | N/A | N/A | N/A | $576K | N/A | N/A | N/A |
| Cash & Equivalents | $35+250.0% | $849+5560.0% | $4K-60.3% | $10-99.7% | $10-68.8% | $15-99.6% | $9K-65.0% | $4K-97.2% | $32-100.0% | $4K-90.7% | $25K-83.2% | $125K+12439.0% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More THC Therapeutics Inc financials
Frequently Asked Questions
THC Therapeutics Inc carried $707K in long-term debt against $35 in cash and equivalents at the end of fiscal year 2024.
THC Therapeutics Inc (THCT) long-term debt was essentially unchanged year over year, at $707K in fiscal year 2024 against $707K the year before.
THC Therapeutics Inc (THCT) reported $707K in long-term debt in Q4 2024. That is unchanged from the same quarter a year earlier.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what THC Therapeutics Inc (THCT) reported on that line in every period on record.